Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2005
03/16/2005CN1192797C Combination vaccine against streptocouus pneumoniae and respiratory syncytial virus (RSV)
03/16/2005CN1192791C Cold preventing Chinese medicine powder and its preparation method
03/16/2005CN1192783C Anti-infection Chinese medicine for clearing heat and detoxicating and its preparing process
03/16/2005CN1192773C Cyclic amine CCR3 antagonisis
03/16/2005CN1192768C Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
03/16/2005CN1192767C Capsule and binding agent for pharmaceutical formulations with improved storage stability
03/15/2005US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents
03/15/2005US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus
03/15/2005US6867230 Antibacterial and antiprotozoal agents
03/15/2005US6867229 Antiparasitic composition for the treatment and protection of pets
03/15/2005US6867227 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer
03/15/2005US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release
03/15/2005US6867033 By administration of PV virus-like particles (VLPs) to a patient suffering from the PV infection
03/15/2005US6866853 Engineering live attenuated viruses which contain a modified nonstructural gene segment; influenza vaccines
03/15/2005US6866852 Expression vector coding genetically engineered F protein of newcastle disease virus for developing poultry vaccine
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/15/2005US6866847 Spraying live avirulent derivative of enteropathogenic bacterium comprising recombinant gene coding for protein expression; respiratory system disorder treatment in birds
03/15/2005US6866782 Process for the purification of pharmacologically active proteins through cationic exchange chromatography
03/15/2005CA2321336C Synthesis of carbamate ketolide antibiotics
03/15/2005CA2170034C Recombinant humanized anti-human immunodeficiency virus antibody
03/15/2005CA2086914C Quinolone-and naphthyridone-carboxylic acid derivatives
03/11/2005WO2005103048A1 Quinolone carboxylic acid derivatives, thereof preparation and usage
03/10/2005WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF
03/10/2005WO2005021595A1 Methods of antibody engineering using antibody display rules
03/10/2005WO2005021575A2 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
03/10/2005WO2005021568A2 Novel tricyclic nucleosides or nucleotides as therapeutic agents
03/10/2005WO2005021559A2 Oxazaborolidines as bacteria effectors
03/10/2005WO2005021046A1 Compositions and methods for delivery of biologically active agents
03/10/2005WO2005021035A1 A bivalent vaccine against fmd, its preparation methods and applications
03/10/2005WO2005021032A1 Live attenuated aldolase-negative bacterial vaccine
03/10/2005WO2005021031A2 Live attenuated bacterial vaccine
03/10/2005WO2005021028A1 Use of modified cyclosporins for the treatment of hcv disorders
03/10/2005WO2005021026A2 Methods for treating or ameliorating ghrelin-associated diseases and disorders
03/10/2005WO2005021020A1 Herbal extracts of salicornia species, process of preparation thereof, use thereof against tuberculosis
03/10/2005WO2005021019A1 Pharmaceutical composition which can be used, for example, as an antiviral or antibacterial agent and to stimulate immune defences
03/10/2005WO2005021007A1 Prevention and treatment of viral hepatitis c
03/10/2005WO2005021001A1 Combinations of a pyrimidine containing nnrti with rt inhibitors
03/10/2005WO2005020997A1 Compositions for veterinary and medical applications
03/10/2005WO2005020990A1 Antibiotic thiazolidines
03/10/2005WO2005020974A1 Novel use of a polyamine-poor composition for the production of a medical human food
03/10/2005WO2005020973A2 Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxylamine
03/10/2005WO2005020884A2 Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
03/10/2005WO2005007192A3 Cytoprotection through the use of hif hydroxylase inhibitors
03/10/2005WO2005005436A3 Cross-linked glycopeptide-cephalosporin antibiotics
03/10/2005WO2005000863A3 6, 11-4c-bicyclic 9a-azalide derivatives
03/10/2005WO2004105492A8 Aqueous compositions for disinfection and/or sterilization
03/10/2005WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
03/10/2005US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/10/2005US20050054721 3-Aryl-4-Hydroxyfuranone compounds and the human and animal health use thereof
03/10/2005US20050054719 Dimeric compounds and their use as anti-viral agents
03/10/2005US20050054718 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054697 useful for the treatment or prophylaxis of bacterial infections in mammals
03/10/2005US20050054683 Microbiocides; bacteriocides; oxazolidinone compound
03/10/2005US20050054675 Interferon $g(g) production promoter
03/10/2005US20050054674 Activator of peroxisome proliferator-activated receptor
03/10/2005US20050054666 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
03/10/2005US20050054657 Induce immunology response; anticancer agents
03/10/2005US20050054645 Aids therapy; side effect reduction
03/10/2005US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054609 Use of polysaccharide derivatives as anti-infective substances
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054594 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
03/10/2005US20050054590 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
03/10/2005US20050054588 Methods and compositions for the treatment of asthma and related disorders
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054095 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
03/10/2005US20050054074 Cell line comprising embryonated poultry cells and attenuated viral particles for use as tool in generation of vaccine for treatment and prevention of in fection by of influenza virus; immunotherapeutics
03/10/2005US20050054052 Therapeutic cytokine for use in prevention and treatment of viral diseases
03/10/2005US20050054038 High level constitutive production of anthrax protective antigen
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053920 Retrovirus from the HIV group and its use
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases
03/10/2005US20050053681 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
03/10/2005US20050053641 Method of treating irritable bowel syndrome
03/10/2005US20050053627 Vaccines for Mycoplasma bovis and methods of use
03/10/2005US20050053616 peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens
03/10/2005US20050053578 For use as wound closure adhesives
03/10/2005US20050053577 Linking low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol, which is released when hydrolysis occurs; for treatment of cancer
03/10/2005US20050053516 antiseptic mixtures of quaternary ammonium compounds and carriers, for use in disinfecting fluids and biological tissues and surfaces contaminated with fluids and/or biological tissues
03/10/2005CA2765058A1 Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
03/10/2005CA2548483A1 Induction of antiviral neutralizing antibodies in humans and animals
03/10/2005CA2546482A1 Compositions and methods for delivery of biologically active agents
03/10/2005CA2541971A1 Herbal extracts of salicornia species, process of preparation thereof, use thereof against tuberculosis
03/10/2005CA2537137A1 Use of modified cyclosporins for the treatment of hcv disorders
03/10/2005CA2535527A1 Immunogenic hiv compositions and related methods
03/10/2005CA2535526A1 Laccases, nucleic acids encoding them and methods for making and using them
03/10/2005CA2534579A1 Live attenuated bacterial vaccine
03/10/2005CA2534453A1 Live attenuated aldolase-negative bacterial vaccine
03/10/2005CA2533690A1 Use of a polyamine-poor composition for the production of a medical human food
03/10/2005CA2529710A1 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/09/2005EP1512693A2 Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
03/09/2005EP1512689A1 Process for producing 3-cephem compounds
03/09/2005EP1512688A1 Use of K-252a derivatives for the treatment of Parkinson's disease
1 ... 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 ... 1798